Faecal transplants ‘show promise’ for immune-mediated colitis
11 out of 12 patients with refractory immune checkpoint inhibitor-induced colitis achieved clinical remission, US doctors report.
Patients with refractory immune checkpoint inhibitor-induced colitis may benefit from faecal microbiota transplants, according to a study in Science Translational Medicine.
Doctors from the University of Texas MD Anderson Cancer Center and UTHealth in Houston reported a case series of 12 patients with refractory immune-mediated colitis who underwent faecal microbiota transplantation (FMT) from healthy donors as salvage therapy.
